arrow
Y

Yasuhiro Kodera

Department of Gastroenterological Surgery
H指数:82
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical practice guidelines for duodenal cancer 2025

2025年十二指肠癌临床实践指南

2026-09-050
PRE
Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (study rindo)

日本转移性结直肠癌患者中,FOLFIRI联合低剂量伊立替康与雷莫芦单抗作为二线治疗的II期研究(研究rindo)

2025-12-010
OA
Overexpression of cat eye syndrome chromosome region, candidate 2 in esophageal squamous carcinoma cell promotes tumor aggressiveness by facilitating NF-κB signaling and inhibition of p53-associated apoptosis

食道鳞状细胞癌细胞中猫眼综合征染色体区域候选2基因的过表达通过促进NF-κB信号通路和抑制p53相关凋亡来增强肿瘤侵袭性。

2025-08-040
PRE
Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasis

亚洲关于胃癌腹膜转移患者腹腔内及全身性常温治疗的共识

2025-07-140
OAAI
Survey of healthcare professionals' awareness of appearance care for Japanese cancer patients and their institutions' appearance care systems: report from the Japan Society of Clinical Oncology

对日本癌症患者外貌护理意识及医疗机构外貌护理系统的调查:日本临床肿瘤学会报告

2025-02-170
PRE
Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study) ( oct , 10.1007/s10120-024-01555-w , 2024)

曲妥珠单抗-deruxtecan在日本HER2-positive晚期胃癌患者中的真实世界有效性和安全性 (EN-DEAVOR研究) (10月,10.1007/s10120-024-01555-w,2024)

2024-11-280
OAAI
The landscape of 142 Epstein-Barr viral whole genomes in gastric cancer

胃癌中142爱泼斯坦-巴尔病毒全基因组的景观

2024-11-210
PRE
Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study)

曲妥珠单抗-deruxtecan在日本HER2-positive晚期胃癌患者中的真实世界有效性和安全性 (EN-DEAVOR研究)

2024-10-102
OAAI
Preclinical toxicological assessment of amido-bridged nucleic acid-modified antisense oligonucleotides targeting synaptotagmin XIII for intra-abdominal treatment of peritoneal metastasis of gastric cancer

针对突触结合蛋白XIII的氨基桥接核酸修饰的反义寡核苷酸用于腹腔内治疗胃癌腹膜转移的临床前毒理学评估

2024-08-270
PRE